Cargando…
The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma
This paper presents a case of hymenoptera venom anaphylaxis averted by omalizumab, a monoclonal antibody to IgE antibody. This case suggests a novel and unintentional effect of this therapy. Currently omalizumab is only FDA approved for the treatment of moderate-persistent allergic asthma. However c...
Autores principales: | Slaughter, Evelyn M., Boyer, Nathan, Bennett, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144081/ https://www.ncbi.nlm.nih.gov/pubmed/25180038 http://dx.doi.org/10.1155/2014/138963 |
Ejemplares similares
-
Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
por: Sahiner, Umit Murat, et al.
Publicado: (2019) -
Takotsubo cardiomyopathy caused by epinephrine-treated bee sting anaphylaxis: a case report
por: Ghanim, Diab, et al.
Publicado: (2015) -
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
por: Song, Xiaoting, et al.
Publicado: (2023) -
Twelve-Hour Ultrarush Immunotherapy in a Patient With Mastocytosis and Hymenoptera Sting Anaphylaxis
por: Jäger, Doris, et al.
Publicado: (2009) -
An Unusual Case of Bilateral Empyema Associated with Bee Sting
por: Venkataramanappa, Srinivasa Kaligonahalli, et al.
Publicado: (2014)